|
|
|
|
| LEADER |
00000nam a2200000 i 4500 |
| 001 |
b9984579 |
| 003 |
CoU |
| 005 |
20240612200354.4 |
| 008 |
171215s2017 dcu l f000 0 eng c |
| 035 |
|
|
|a (OCoLC)ocn1015373866
|
| 035 |
|
|
|a tmp97448988
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|c GPO
|d MvI
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COD9
|
| 074 |
|
|
|a 0575
|
| 086 |
0 |
|
|a AE 2.110:115-52
|
| 086 |
0 |
|
|a AE 2.110:115-52
|
| 088 |
|
|
|a Public Law 115-52
|
| 110 |
1 |
|
|a United States,
|e enacting jurisdiction.
|0 http://id.loc.gov/authorities/names/n78095330
|1 http://isni.org/isni/0000000123315230.
|
| 240 |
1 |
0 |
|a FDA Reauthorization Act of 2017
|0 http://id.loc.gov/authorities/names/no2017163942.
|
| 245 |
1 |
3 |
|a An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes.
|
| 264 |
|
1 |
|a [Washington, D.C.] :
|b [U.S. Government Publishing Office],
|c 2017.
|
| 300 |
|
|
|a 86 unnumbered pages ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
| 500 |
|
|
|a Shipping list number: 2018-0084-P.
|
| 500 |
|
|
|a "Aug. 18, 2017 (H.R. 2430)."
|
| 500 |
|
|
|a "131 Stat. 1005."
|
| 500 |
|
|
|a "Public Law 115-52."
|
| 590 |
|
|
|a Statutes at large copy bound with 90 other public laws (P.L. 115-1 – 115-90)
|
| 650 |
|
0 |
|a Drugs
|x Prices
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Prescription pricing
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Medical instruments and apparatus industry
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Generic drugs
|x Prices
|z United States.
|
| 650 |
|
0 |
|a Biologicals
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a User charges
|x Law and legislation
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2010117605.
|
| 655 |
|
7 |
|a Statutes and codes.
|2 lcgft
|0 http://id.loc.gov/authorities/genreForms/gf2011026611.
|
| 776 |
0 |
8 |
|i Online version:
|a United States.
|s FDA Reauthorization Act of 2017.
|t Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes
|w (OCoLC)1015373781.
|
| 907 |
|
|
|a .b99845799
|b 03-19-20
|c 01-09-18
|
| 998 |
|
|
|a gov
|b 01-09-18
|c -
|d m
|e -
|f eng
|g dcu
|h 3
|i 2
|
| 907 |
|
|
|a .b99845799
|b 02-01-18
|c 01-09-18
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 907 |
|
|
|a .b99845799
|b 01-10-18
|c 01-09-18
|
| 999 |
f |
f |
|i 4ea10d14-5f10-5fa5-a801-eaa59118d92b
|s 05456d3b-6d80-51b0-b835-6dcd7f584b3b
|
